Biotech Investors & VC Firms in Europe
1049 firms in this list, with a median first check of $500K. 293 of them lead rounds. Generated from verified public data and updated continuously.
Global Health Impact Fund
San RamonPre-Seed–Series A
1 person
Pearls Capital
DohaSeed–Series A
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Bioscience Equity Partners
DubaiLate Stage
1 person
Heights
Hong KongGrowth–Late Stage
1 person
Fosun Pharma
Shanghai
JMCR Partners
Hong KongSeed–Late Stage
Onex Corporation
TorontoGrowth–Late Stage
eureKARE
Seed
NF Trinity
Hong KongSeed–Growth
Dow Venture Capital
MidlandSeed–Series A$250K – $5M
1 person
10x Genomics
Pleasanton
4 people
Yonjin Venture LLC
CambridgeSeed–Series B
2 people
Providence Investment Company Limited
GermanySeed–Growth
Hermes-Epitek
HsinchuSeed
1 person
Sequoia Biotech Consulting
Encinitas
1 person
MEIF Proof-of-Concept & Early Stage Fund
Seed–Series A
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.









